Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Crypto Market Update: Bitcoin ETFs Log Record Outflow Over Last Two Months January 3, 2026 Bold Ventures Closes $776,800 Non-Brokered Private Placement January 3, 2026 Westport Announces Board of Directors Update January 3, 2026